Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers

Lasers in Surgery and Medicine

Volumn 44, Issue 2, 2012, Pages 117-124

  Kauvar, Arielle N B ^a,b  

^a New York Laser and Skin Care   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chloasma; hyperpigmentation; low fluence laser; melanin; melanocytes; melanosome; microdermabrasion; mixed type melasma; Nd:YAG laser; phototypes; pigment

Indexed keywords

ASCORBIC ACID; HYDROQUINONE; RETINOIC ACID; SUNSCREEN;

ADULT; ARTICLE; CHLOASMA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DRUG SAFETY; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; NEODYMIUM LASER; OBSERVATIONAL STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SAFETY; SKIN ABRASION; SKIN CARE; SKIN IRRITATION; SUN EXPOSURE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; COMBINED MODALITY THERAPY; DERMABRASION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROQUINONES; KERATOLYTIC AGENTS; LASERS; LASERS, SOLID-STATE; MELANOSIS; MIDDLE AGED; SINGLE-BLIND METHOD; SUNSCREENING AGENTS; TREATMENT OUTCOME; TRETINOIN;

EID: 84857216320     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.21156     Document Type: Article

References (48)

1. Grimes PE,. Melasma. Etiologic and therapeutic considerations. Arch Dermatol 1995; 131: 1453-1457.
2. Gupta AK, Gover MD, Nouri K, Taylor S,. The treatment of melasma: A review of clinical trials. J Am Acad Dermatol 2006; 55: 1048-1065. (Pubitemid 44716465)
3. Vazquez M, Maldonado H, Benmaman C, Sanchez JL,. Melasma in men. A clinical and histologic study. Int J Dermatol 1988; 27: 25-27. (Pubitemid 18061166)
4. Goh CL, Dlova CN,. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J 1999; 40: 455-458. (Pubitemid 29376897)
5. Pawaskar MD, Parikh P, Markowski T, McMichael AJ, Feldman SR, Balkrishnan R,. Melasma and its impact on health-related quality of life in Hispanic women. J Dermatol Treat 2007; 18: 5-9. (Pubitemid 46410634)
6. Polnikorn N,. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: Two case reports. J Cosmet Laser Ther 2008; 10: 167-173.
7. Taylor SC, Torok H, Jones T, Lowe N, Rich P, Tschen E, Menter A, Baumann L, Wieder JJ, Jarratt MM, Pariser D, Martin D, Weiss J, Shavin J, Ramirez N,. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis 2003; 72: 67-72. (Pubitemid 37229761)
8. Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC Jr., Melasma: A clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981; 4: 698-710. (Pubitemid 11038002)
9. Grimes PE, Yamada N, Bhawan J,. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Am J Dermatopathol 2005; 27: 96-101. (Pubitemid 40471093)
10. Rendon M, Berneburg M, Arellano I, Picardo M,. Treatment of melasma. J Am Acad Dermatol 2006; 54: S272-S281.
11. Pichardo R, Vallejos Q, Feldman SR, Schulz MR, Verma A, Quandt SA, Arcury TA,. The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. Int J Dermatol 2009; 48: 22-26.
12. Balkrishnan R, Kelly AP, McMichael A, Torok H,. Improved quality of life with effective treatment of facial melasma: The pigment trial. J Drugs Dermatol 2004; 3: 377-381.
13. Freitag FM, Cestari TF, Leopoldo LR, Paludo P, Boza JC,. Effect of melasma on quality of life in a sample of women living in southern Brazil. J Eur Acad Dermatol Venereol 2008; 22: 655-662. (Pubitemid 351682188)
14. Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S, Feldman SR, Chren MM,. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 2003; 149: 572-577. (Pubitemid 37281590)
15. Grimes P, Nordlund JJ, Pandya AG, Taylor S, Rendon M, Ortonne JP,. Increasing our understanding of pigmentary disorders. J Am Acad Dermatol 2006; 54: S255-S261. (Pubitemid 44316605)
16. Grimes PE,. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation. Cutis 2004; 74: 362-368. (Pubitemid 40125978)
17. Gilchrest BA,. A review of skin ageing and its medical therapy. Br J Dermatol 1996; 135: 867-875. (Pubitemid 26397913)
18. Prignano F, Ortonne JP, Buggiani G, Lotti T,. Therapeutical approaches in melasma. Dermatol Clin 2007; 25: 337-342, viii. (Pubitemid 47088892)
19. Majid I,. Mometasone-based triple combination therapy in melasma: Is it really safe ? Indian J Dermatol 2010; 55: 359-362.
20. Stratigos AJ, Dover JS, Arndt KA,. Lasers and aesthetic dermatology. Hautarzt 2003; 54: 603-613. (Pubitemid 36841497)
21. Grekin RC, Shelton RM, Geisse JK, Friden I,. 510-nm pigmented lesion dye laser. Its characteristics and clinical uses. J Dermatol Surg Oncol 1993; 19: 380-387. (Pubitemid 24175661)
22. Taylor CR, Anderson RR,. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol 1994; 20: 592-597. (Pubitemid 24292440)
23. Kopera D, Hohenleutner U,. Ruby laser treatment of melasma and postinflammatory hyperpigmentation. Dermatol Surg 1995; 21: 994.
24. Negishi K, Kushikata N, Tezuka Y, Takeuchi K, Miyamoto E, Wakamatsu S,. Study of the incidence and nature of "very subtle epidermal melasma" in relation to intense pulsed light treatment. Dermatol Surg 2004; 30: 881-886, discussion 886. (Pubitemid 38765727)
25. Nouri K, Bowes L, Chartier T, Romagosa R, Spencer J,. Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: A pilot study. Dermatol Surg 1999; 25: 494-497. (Pubitemid 29279595)
26. 2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: Split-face design. Dermatol Surg 2003; 29: 59-64. (Pubitemid 36114731)
27. Manaloto RM, Alster T,. Erbium: YAG laser resurfacing for refractory melasma. Dermatol Surg 1999; 25: 121-123. (Pubitemid 30195951)
28. Kroon MW, Wind BS, Beek JF, van der Veen JP, Nieuweboer-Krobotová L, Bos JD, Wolkerstorfer A,. Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled pilot study. J Am Acad Dermatol 2011; 64: 516-523.
29. Rokhsar CK, Fitzpatrick RE,. The treatment of melasma with fractional photothermolysis: A pilot study. Dermatol Surg 2005; 31: 1645-1650. (Pubitemid 43031166)
30. Tannous ZS, Astner S,. Utilizing fractional resurfacing in the treatment of therapy-resistant melasma. J Cosmet Laser Ther 2005; 7: 39-43. (Pubitemid 40896751)
31. Katz TM, Glaich AS, Goldberg LH, Firoz BF, Dai T, Friedman PM,. Treatment of melasma using fractional photothermolysis: A report of eight cases with long-term follow-up. Dermatol Surg 2010; 36: 1273-1280.
32. Karsai S, Fischer T, Pohl L, Schmitt L, Buhck H, Jünger M, Raulin C,. Is non-ablative 1550-nm fractional photothermolysis an effective modality to treat melasma? Results from a prospective controlled single-blinded trial in 51 patients. J Eur Acad Dermatol Venereol 2011.
33. Wind BS, Kroon MW, Meesters AA, Beek JF, van der Veen JP, Nieuweboer-Krobotová L, Bos JD, Wolkerstorfer A,. Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled split-face study. Lasers Surg Med 2010; 42: 607-612.
34. Zhou X, Gold MH, Lu Z, Li Y,. Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma. Dermatol Surg 2011; 37: 962-970.
35. Polnikorn N,. Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: A prospective study. J Cosmet Laser Ther 2010; 12: 126-131.
36. Suh KS, Sung JY, Roh HJ, Jeon YS, Kim YC, Kim ST,. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma. J Dermatol Treat 2011; 22: 233-238.
37. Wattanakrai P, Mornchan R, Eimpunth S,. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg 2010; 36: 76-87.
38. Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH,. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. Lasers Surg Med 2010; 42: 712-719.
39. Kim MJ, Kim JS, Cho SB,. Punctate leucoderma after melasma treatment using 1064-nm Q-switched Nd:YAG laser with low pulse energy. J Eur Acad Dermatol Venereol 2009; 23: 960-962.
40. Anderson RR, Margolis RJ, Watenabe S, Flotte T, Hruza GJ, Dover JS,. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532 and 355 nm. J Invest Dermatol 1989; 93: 28-32. (Pubitemid 19183307)
41. Anderson RR, Parrish JA,. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220: 524-527. (Pubitemid 13114117)
42. Hruza GJ, Dover JS, Flotte TJ, Goetschkes M, Watanabe S, Anderson RR,. Q-switched ruby laser irradiation of normal human skin. Histologic and ultrastructural findings. Arch Dermatol 1991; 127: 1799-1805.
43. Polla LL, Margolis RJ, Dover JS, Whitaker D, Murphy GF, Jacques SL, Anderson RR,. Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin. J Invest Dermatol 1987; 89: 281-286. (Pubitemid 17126581)
44. Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR,. Fractional photothermolysis: A new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34: 426-438. (Pubitemid 38890753)
45. Laubach HJ, Tannous Z, Anderson RR, Manstein D,. Skin responses to fractional photothermolysis. Lasers Surg Med 2006; 38: 142-149.
46. Gy S, Ho N, Chan C, Yeung C, Shek S, Chan H,. Efficacy of 1,927-nm thulium fiber laser for the treatment of melasma in Chinese patients. Presented at the annual meeting of the American Society for Laser Medicine and Surgery, April 2011.
47. Kim T, Cho SB, Oh SH,. Punctate leucoderma after 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser with low-fluence therapy: Is it melanocytopenic or melanopenic ? Dermatol Surg 2010; 36: 1790-1791.
48. Mun JY, Jeong SY, Kim JH, Han SS, Kim IH,. A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. J Electron Microsc (Tokyo) 2011; 60: 11-18.